SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 13.94 |
| Enterprise Value ($M) | 11.57 |
| Book Value ($M) | 0.84 |
| Book Value / Share | 0.16 |
| Price / Book | 16.65 |
| NCAV ($M) | -0.27 |
| NCAV / Share | -0.05 |
| Price / NCAV | -52.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.44 |
| Return on Assets (ROA) | -2.97 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.13 |
| Current Ratio | 1.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.62 |
| Assets | 3.72 |
| Liabilities | 2.89 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.06 |
| Operating Income | -8.00 |
| Net Income | -7.95 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -8.03 |
| Cash from Investing | -0.01 |
| Cash from Financing | 9.30 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Satterfield Thomas A Jr | 8.20 | -77.18 | |
| 13G | Intracoastal Capital, Llc | 4.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| March, 26, 2025 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,644 | 32,923 | 20.18 | |
| 6,482 | 15,797 | 41.03 | |
| 16,457 | 51,141 | 32.18 | |
| 24,906 | 75,729 | 32.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATYR – aTyr Pharma, Inc. | AVTX – Avalo Therapeutics, Inc. |
| AYTU – Aytu BioPharma, Inc. | BCLI – Brainstorm Cell Therapeutics Inc. |
| BCTX – BriaCell Therapeutics Corp. |
Financial data and stock pages provided by
Fintel.io